These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15832429)

  • 1. Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus.
    Pan L; Jia ZS; Chen L; Fu EQ; Li GY
    World J Gastroenterol; 2005 Apr; 11(16):2518-21. PubMed ID: 15832429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment.
    Chen L; Bao D; Gu L; Gu Y; Zhou L; Gao Z; Huang Y
    BMC Infect Dis; 2018 Jul; 18(1):295. PubMed ID: 29970037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.
    Lomtadze N; Kupreishvili L; Salakaia A; Vashakidze S; Sharvadze L; Kempker RR; Magee MJ; del Rio C; Blumberg HM
    PLoS One; 2013; 8(12):e83892. PubMed ID: 24367617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus.
    Mo P; Zhu Q; Teter C; Yang R; Deng L; Yan Y; Chen J; Zeng J; Gui XE
    Int J Infect Dis; 2014 Nov; 28():95-100. PubMed ID: 25218771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection.
    Wong WM; Wu PC; Yuen MF; Cheng CC; Yew WW; Wong PC; Tam CM; Leung CC; Lai CL
    Hepatology; 2000 Jan; 31(1):201-6. PubMed ID: 10613746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on liver damage caused by anti-TB drug intermittent treatment on patients with HBV-TB co-infection].
    Huang LH; Geng WK; Zhang J; Lin DW; Dong F; Zhou LS; Dong YR; Zhang XW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):286-9. PubMed ID: 19642388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral hepatitis prevalence in patients with active and latent tuberculosis.
    Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
    World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: A systematic review and meta-analysis.
    Chou C; Veracruz N; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 Dec; 29(12):1107-1114. PubMed ID: 36138556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline HBV load increases the risk of anti-tuberculous drug-induced hepatitis flares in patients with tuberculosis.
    Zhu CH; Zhao MZ; Chen G; Qi JY; Song JX; Ning Q; Xu D
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):105-109. PubMed ID: 28224437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis B virus infection: clinical implications in tuberculosis treatment.
    Trigo C; do Brasil PE; Costa MJ; de Castro L
    J Viral Hepat; 2016 Dec; 23(12):1027-1035. PubMed ID: 27624908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis in children with tuberculosis: a case report and review of the literature.
    Sanchez-Codez M; Hunt WG; Watson J; Mejias A
    BMC Pulm Med; 2020 Jun; 20(1):173. PubMed ID: 32546255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis.
    Liu YM; Cheng YJ; Li YL; Liu CE; Hsu WH
    Lung; 2014 Feb; 192(1):205-10. PubMed ID: 24292367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of chronic viral hepatitis on tuberculosis treatment interruption.
    Chua AP; Lim LK; Gan SH; Chee CB; Wang YT
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1486-1494. PubMed ID: 30606322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
    Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
    BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies.
    Zheng J; Guo MH; Peng HW; Cai XL; Wu YL; Peng XE
    Epidemiol Infect; 2020 Nov; 148():e290. PubMed ID: 33222713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients.
    Tostmann A; van den Boogaard J; Semvua H; Kisonga R; Kibiki GS; Aarnoutse RE; Boeree MJ
    Trop Med Int Health; 2010 Feb; 15(2):268-72. PubMed ID: 20409289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand.
    Sirinak C; Kittikraisak W; Pinjeesekikul D; Charusuntonsri P; Luanloed P; Srisuwanvilai LO; Nateniyom S; Akksilp S; Likanonsakul S; Sattayawuthipong W; Burapat C; Varma JK
    BMC Public Health; 2008 Jul; 8():245. PubMed ID: 18638392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required.
    Puga MAM; Bandeira LM; Pompilio MA; Rezende GR; Soares LS; de Castro VOL; Tanaka TSO; Cesar GA; de Oliveira SMDVL; Teles SA; Yassuda RTS; Weis-Torres SMDS; Basílio SF; Croda J; Motta-Castro ARC
    PLoS One; 2019; 14(8):e0221265. PubMed ID: 31437184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intervention efficacy of lamivudine on liver dysfunction in patients undergoing anti-tuberculosis treatment for pulmonary tuberculosis complicated with 
chronic hepatitis B: a Meta-analysis].
    Hui S; Chen L; Li Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 40(8):912-20. PubMed ID: 26333502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.